Doxorubicin, dacarbazine, vincristine, and cyclophosphamide in the treatment of advanced gastrointestinal leiomyosarcoma.
A multidrug regimen of doxorubicin, dacarbazine, vincristine, and cyclophosphamide produced response in 33% of patients with advanced gastrointestinal leiomyosarcoma. Except for one patient, the duration of response was short and prolongation of survival was not affected.